Relapsed or Refractory Aggressive B-cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Aggressive B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma (NCT06996132) | Institute of Hematology & Blood Diseases Hospital, China | 2025-05-09 |
Track Relapsed or Refractory Aggressive B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.